This study intended to measure the expression of complement regulatory proteins CD55 and CD59 on RBCs membrane in patients with β-thalassemia (β- thal) major in addition to investigate if splenectomy affects their expression pattern. This was a case-control study, participants were allocated in three groups. The study group 1 consisted of β-thal patients who underwent splenectomy. The study group 2 consisted of β-thal patients without splenectomy. Group 3 consisted of apparently healthy volunteers as a control group. A significant decrease in CD55 expression in patients' group 1 (46.35±14.61) and group 2 (56.90±9.28) in comparison with group 3 (86.20±9.62) was observed. The percentage of CD55 expression was significantly lower in group 1 patients than group 2 (P=0.01). However, there was no difference in the percentage of CD59 marker expression between any of the patient's groups and the control group. In conclusion, CD55 under-expression on RBCs of β- thal patients may be considered one of the factors that cause hemolysis in those patients and this complement mediated hemolysis may be one of the underlying causes of organ damage. Additional deficiency of this receptor occurs with splenectomy.
Download full-text PDF |
Source |
---|
Vasa
January 2025
Department of Cardiology, Kafkas University School of Medicine, Kars, Turkey.
Percutaneous superficial femoral interventions remain the preferred method of treatment for superficial femoral artery (SFA) disease. Nevertheless, long term restenosis continues to be a major limitation of percutaneous interventions. In this context, the objective of this study is to compare the efficacies of CHA2DS2-VASc, CHA2DS2-VASc-HS, ATRIA, ATRIA-HSV, and HATCH risk scoring systems in predicting long-term (5 years) restenosis due to percutaneous interventions to the superficial femoral artery.
View Article and Find Full Text PDFGlob Reg Health Technol Assess
January 2025
Omakase Consulting S.L., Barcelona - Spain.
Background: Activated phosphoinositide 3-kinase (PI3K) δ Syndrome (APDS) is an ultra-rare, potentially life-threatening disease that lacks approved treatments in Spain. This study aimed to apply Multi-Criteria Decision Analysis (MCDA) to assess the value of the first pharmacological treatment for APDS in Spain.
Methods: A multidisciplinary group of 8 experts evaluated the selective PI3Kδ inhibitor leniolisib against Standard of Care (SoC).
Front Endocrinol (Lausanne)
January 2025
Department of Trauma Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
Background: Previous studies have shown that dyslipidemia is significantly associated with primary frozen shoulder and may be a risk factor for the development of primary frozen shoulder. However, these findings may be biased by a number of confounding factors. We investigated the association between serum lipids and primary frozen shoulder by retrospective analysis and two-sample Mendelian randomization (MR) methods.
View Article and Find Full Text PDFCureus
January 2025
General Surgery, Croydon University Hospital, London, GBR.
Background Laparoscopic appendicectomy is a commonly used approach for the surgical management of acute appendicitis. If complications arise, a blood transfusion may be necessary for patients undergoing emergency appendicectomy. The need for routine group and save (G&S) sampling prior to emergency laparoscopic appendicectomy remains a subject of ongoing discussion.
View Article and Find Full Text PDFFront Oral Health
January 2025
Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Objectives: This study aims to examine kindergarten teachers' satisfaction and their perceived impact of an oral health education (OHE) training program.
Methods: This study followed the steps outlined in the Program Evaluation Standards in Public Health recommended by the Centers for Disease Control and Prevention. All kindergarten teachers in Hong Kong were invited to attend the OHE training.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!